Contact: Dana Kauffman, email@example.com, 202-375-6294
WASHINGTON (Jul 14, 2020) -
The 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants will publish online on Tuesday, July 14, at 2:00 p.m. ET in the Journal of the American College of Cardiology. To review an embargoed copy of this paper, please contact Dana Kauffman.
This Expert Consensus Decision Pathway (ECDP) focuses on the management of bleeding in patients being treated with direct oral anticoagulants and vitamin K antagonists for any indication. The primary goal is to guide the management of acute bleeding in patients treated with oral anticoagulants (OACs) and to supplement the 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation, which addresses the management of patients undergoing planned surgical or interventional procedures. This update to the 2017 ECDP was created due to the emergence of new OACs for use in the prevention of venous thromboembolism and the introduction of new reversal strategies for factor Xa (FXa) inhibitors. The recommendations in this ECDP include guidance for temporary or permanent interruption of therapy, general approaches to bleeding management, decision support for treatment with a reversal agent, and indications and timing for reinstituting anticoagulant treatment.
The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.
The Journal of the American College of Cardiology ranks among the top cardiovascular journals in the world for its scientific impact. JACC is the flagship for a family of journals—JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, JACC: Heart Failure, JACC: Clinical Electrophysiology, JACC: Basic to Translational Science, JACC: Case Reports and JACC: CardioOncology—that prides themselves in publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.